This study is testing a new medicine called **NNC0519-0130** to see if it helps people with type 2 diabetes lower their blood sugar and lose weight. Type 2 diabetes is a condition where the body doesn't use insulin properly, leading to high blood sugar levels. Insulin is a hormone that helps sugar enter cells for energy. The study will test up to seven different doses of NNC0519-0130, which will be given as 1-3 injections weekly. Injections are when medicine is put into the body using a needle. The needle is thin and can be injected into the stomach, thigh, or upper arm. This study lasts about 40 weeks, which is around 10 months.

• Participants must be adults aged 18-75 with type 2 diabetes.
• The study involves weekly injections and lasts for about 40 weeks.
• It's important to discuss any other diabetes or weight-related medications with the study team.